Akt and p53R2, partners that dictate the progression and invasiveness of cancer
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in DNA Repair
- Vol. 22, 24-29
- https://doi.org/10.1016/j.dnarep.2014.07.001
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Activation of the phosphatidylinositol 3′-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1Human Pathology, 2011
- Akt, FoxO and regulation of apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cellsBiochemical and Biophysical Research Communications, 2011
- Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerCancer and Metastasis Reviews, 2009
- Switching Akt: from survival signaling to deadly responseBioEssays, 2009
- ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damageProceedings of the National Academy of Sciences of the United States of America, 2008
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53Online Journal of Public Health Informatics, 2002